The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 29, 2026
Filed:
May. 05, 2021
Applicant:
Cytokinetics, Inc., South San Francisco, CA (US);
Inventors:
Antonio Romero, San Mateo, CA (US);
Aroop Chandra, Carmel, IN (US);
Christopher Evans, Pacifica, CA (US);
Minxing Shen, San Bruno, CA (US);
Assignee:
CYTOKINETICS, INC., South San Francisco, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 205/04 (2006.01); C07C 275/18 (2006.01); C07C 275/26 (2006.01); C07C 311/13 (2006.01); C07C 311/20 (2006.01); C07C 317/30 (2006.01); C07C 317/32 (2006.01); C07D 205/12 (2006.01); C07D 207/06 (2006.01); C07D 207/08 (2006.01); C07D 207/267 (2006.01); C07D 209/08 (2006.01); C07D 209/44 (2006.01); C07D 209/54 (2006.01); C07D 211/26 (2006.01); C07D 211/58 (2006.01); C07D 211/78 (2006.01); C07D 213/38 (2006.01); C07D 213/40 (2006.01); C07D 213/56 (2006.01); C07D 213/65 (2006.01); C07D 213/68 (2006.01); C07D 213/71 (2006.01); C07D 213/74 (2006.01); C07D 213/75 (2006.01); C07D 213/81 (2006.01); C07D 213/82 (2006.01); C07D 213/87 (2006.01); C07D 215/06 (2006.01); C07D 215/08 (2006.01); C07D 217/04 (2006.01); C07D 221/20 (2006.01); C07D 231/12 (2006.01); C07D 231/14 (2006.01); C07D 231/56 (2006.01); C07D 239/26 (2006.01); C07D 241/04 (2006.01); C07D 241/08 (2006.01); C07D 241/12 (2006.01); C07D 249/06 (2006.01); C07D 249/08 (2006.01); C07D 261/08 (2006.01); C07D 263/56 (2006.01); C07D 265/36 (2006.01); C07D 271/10 (2006.01); C07D 295/16 (2006.01); C07D 295/182 (2006.01); C07D 305/08 (2006.01); C07D 307/22 (2006.01); C07D 309/08 (2006.01); C07D 335/02 (2006.01); C07D 401/04 (2006.01); C07D 401/06 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 403/04 (2006.01); C07D 403/10 (2006.01); C07D 403/12 (2006.01); C07D 405/06 (2006.01); C07D 413/06 (2006.01); C07D 413/12 (2006.01); C07D 471/04 (2006.01);
U.S. Cl.
CPC ...
C07C 275/26 (2013.01); C07C 275/18 (2013.01); C07C 311/13 (2013.01); C07C 311/20 (2013.01); C07C 317/30 (2013.01); C07C 317/32 (2013.01); C07D 205/04 (2013.01); C07D 205/12 (2013.01); C07D 207/06 (2013.01); C07D 207/08 (2013.01); C07D 207/267 (2013.01); C07D 209/08 (2013.01); C07D 209/44 (2013.01); C07D 209/54 (2013.01); C07D 211/26 (2013.01); C07D 211/58 (2013.01); C07D 211/78 (2013.01); C07D 213/38 (2013.01); C07D 213/40 (2013.01); C07D 213/56 (2013.01); C07D 213/65 (2013.01); C07D 213/68 (2013.01); C07D 213/71 (2013.01); C07D 213/74 (2013.01); C07D 213/75 (2013.01); C07D 213/81 (2013.01); C07D 213/82 (2013.01); C07D 213/87 (2013.01); C07D 215/06 (2013.01); C07D 215/08 (2013.01); C07D 217/04 (2013.01); C07D 221/20 (2013.01); C07D 231/12 (2013.01); C07D 231/14 (2013.01); C07D 231/56 (2013.01); C07D 239/26 (2013.01); C07D 241/04 (2013.01); C07D 241/08 (2013.01); C07D 241/12 (2013.01); C07D 249/06 (2013.01); C07D 249/08 (2013.01); C07D 261/08 (2013.01); C07D 263/56 (2013.01); C07D 265/36 (2013.01); C07D 271/10 (2013.01); C07D 295/16 (2013.01); C07D 295/182 (2013.01); C07D 305/08 (2013.01); C07D 307/22 (2013.01); C07D 309/08 (2013.01); C07D 335/02 (2013.01); C07D 401/04 (2013.01); C07D 401/06 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/04 (2013.01); C07D 403/10 (2013.01); C07D 403/12 (2013.01); C07D 405/06 (2013.01); C07D 413/06 (2013.01); C07D 413/12 (2013.01); C07D 471/04 (2013.01); C07B 2200/05 (2013.01); C07C 2601/02 (2017.05); C07C 2601/04 (2017.05); C07C 2601/14 (2017.05); C07C 2602/08 (2017.05); C07C 2602/10 (2017.05); C07C 2602/50 (2017.05);
Abstract
Provided are compounds of Formula (II): or a pharmaceutically acceptable salt thereof, wherein R1, n, and Y1 are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formula (II), or a pharmaceutically acceptable salt thereof. Also provided are methods of using a compound of Formula (II), or a pharmaceutically acceptable salt thereof.
Quick Actions:
Romero, Antonio. (2026). Nampt modulators (U.S. Patent No. 12747203). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12747203
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile